Instituto Lilly de Medicina Genética de US$ 700 milhões será desenvolvido em Boston
Eli Lilly and Company, an American pharmaceutical company headquartered in Indianapolis, Indiana has announced plans to develop US$ 700M Lilly Institute for Genetic Medicine in … Saiba mais